Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
78.9M
-
Shares change
-
+573K
-
Total reported value, excl. options
-
$1.99B
-
Value change
-
+$13.5M
-
Put/Call ratio
-
0.11
-
Number of buys
-
88
-
Number of sells
-
-92
-
Price
-
$25.20
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2022
230 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2022.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.9M shares
of 93.1M outstanding shares and own 84.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.8M shares), VANGUARD GROUP INC (8.98M shares), EARNEST PARTNERS LLC (6.28M shares), WELLINGTON MANAGEMENT GROUP LLP (5.1M shares), STATE STREET CORP (4.2M shares), Camber Capital Management LP (3.5M shares), BANK OF AMERICA CORP /DE/ (2.76M shares), DIMENSIONAL FUND ADVISORS LP (2.56M shares), Artisan Partners Limited Partnership (2.33M shares), and D. E. Shaw & Co., Inc. (1.89M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.